Centessa Pharmaceuticals (CNTA)

AI Score

Unlock

12.29

-0.01 (-0.04%)

At close: Apr 21, 2025, 10:38 AM

Centessa Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Cash & Equivalents	383.22M	395.03M	127.37M	118.22M	128.03M	171.5M	145.22M	259.99M	393.64M	444.84M	484.16M	544.47M	595.08M	578.82M	613.76M	298.61M	7.23M
Short-Term Investments	98.96M	123.42M	167.46M	111.96M	128.52M	109.84M	158.37M	86.24M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	2.05M	2.23M	2.38M	1.88M	2.55M	2.1M	2.27M	6.04M	45.98M	1.81M	648K	619K	34.39M	448K	n/a	6.84M	552K
Receivables	45.3M	40.04M	46.99M	37.17M	39.15M	30.39M	28.42M	23.39M	26.72M	21.71M	21.8M	23.14M	16.81M	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	1.00	1.00	17.86M	14.53M	11.58M	-29.99M	9.15M	12.39M	12.47M	-17.81M	10.22M	14.18M	1.39M	n/a
Other Current Assets	1.78M	2.67M	1.95M	1.8M	1.62M	2.86M	3.87M	3.13M	3.27M	1.29M	1.14M	1.12M	993K	24.84M	19.69M	14.71M	3.93M
Total Current Assets	536.41M	568.36M	355.5M	284.48M	315.09M	332.45M	350.41M	384.33M	393.64M	476.99M	519.5M	581.2M	595.08M	611.64M	643.68M	313.64M	11.16M
Property-Plant & Equipment	11.76M	12.06M	12.37M	12.65M	12.95M	13.23M	13.49M	13.49M	1.17M	552K	905K	374K	162K	114K	75K	45K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	40.39M	41.35M	43.34M	43.7M	47.88M	44.91M	42.51M	19.53M	50.66M	2.37M	1.55M	993K	34.55M	562K	75K	6.88M	552K
Total Assets	576.8M	609.72M	398.85M	328.17M	362.97M	377.36M	392.92M	403.86M	444.31M	479.36M	521.05M	582.19M	629.63M	612.21M	643.76M	320.52M	11.72M
Account Payables	7.14M	7.44M	5.32M	7.5M	11.81M	10.85M	11.09M	14.37M	13.84M	10.86M	8.23M	6.69M	7.3M	18.46M	7.26M	12.22M	1.03M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	23.46M	21.82M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	5.63M
Other Current Liabilities	10.18M	18.39M	644K	528K	951K	159K	507K	2.65M	2.27M	509K	222K	1.46M	871K	234K	395K	652K	922K
Total Current Liabilities	58M	26.41M	26.75M	27.43M	39.38M	34.95M	33.87M	29.69M	38.34M	38.19M	33.57M	27.19M	24.64M	29.14M	24.18M	18.98M	8.62M
Long-Term Debt	108.94M	84.14M	76.5M	76.8M	75.7M	74M	73.3M	71.6M	69.8M	68.2M	67.4M	74.8M	75.7M	n/a	n/a	291K	n/a
Other Long-Term Liabilities	29K	29K	29K	29K	29K	n/a	n/a	n/a	n/a	43K	43K	43K	37.74M	33.93M	33.93M	22.62M	n/a
Total Long-Term Liabilities	117.25M	84.17M	85.13M	85.57M	87.34M	83.02M	82.45M	80.91M	108.14M	68.24M	67.44M	74.84M	138.08M	33.93M	33.93M	22.91M	n/a
Total Liabilities	175.25M	110.58M	111.88M	113.01M	126.72M	117.97M	116.31M	110.6M	108.14M	106.43M	101.01M	102.04M	138.08M	63.07M	58.12M	41.89M	8.62M
Total Debt	117.23M	84.72M	85.65M	86.07M	84.59M	83.5M	82.91M	81.31M	69.8M	68.2M	67.4M	74.8M	75.7M	n/a	n/a	291K	5.63M
Common Stock	359K	357K	309K	277K	273K	271K	266K	266K	265K	263K	263K	262K	252K	252K	252K	133K	25.55M
Retained Earnings	-988.7M	-877.37M	-834.81M	-790.99M	-752.95M	-716.11M	-677.46M	-652.57M	-601.86M	-558.69M	-504.81M	-440.15M	-385.65M	-324.88M	-284.72M	-243.27M	-23.84M
Comprehensive Income	4.21M	2.1M	1.59M	1.62M	1.49M	779K	946K	-599K	-1.5M	-1.7M	-1.14M	-18K	688K	2.74M	3.23M	2.13M	572K
Shareholders Equity	401.55M	499.14M	286.96M	215.16M	236.24M	259.39M	276.61M	293.26M	336.17M	372.92M	420.04M	480.15M	491.55M	549.13M	585.64M	278.63M	3.1M
Total Investments	98.96M	123.42M	167.46M	111.96M	128.52M	109.84M	158.37M	86.24M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a